1. Home
  2. DHR vs SYK Comparison

DHR vs SYK Comparison

Compare DHR & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Danaher Corporation

DHR

Danaher Corporation

HOLD

Current Price

$236.30

Market Cap

166.7B

Sector

Industrials

ML Signal

HOLD

Logo Stryker Corporation

SYK

Stryker Corporation

HOLD

Current Price

$364.91

Market Cap

141.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHR
SYK
Founded
1969
1941
Country
United States
United States
Employees
63000
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
166.7B
141.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DHR
SYK
Price
$236.30
$364.91
Analyst Decision
Strong Buy
Buy
Analyst Count
18
16
Target Price
$250.53
$434.19
AVG Volume (30 Days)
2.7M
1.7M
Earning Date
01-28-2026
01-29-2026
Dividend Yield
0.54%
0.97%
EPS Growth
N/A
N/A
EPS
4.87
7.61
Revenue
$24,268,000,000.00
$24,381,000,000.00
Revenue This Year
$3.76
$12.01
Revenue Next Year
$4.06
$8.61
P/E Ratio
$48.49
$47.79
Revenue Growth
2.21
10.95
52 Week Low
$171.00
$329.16
52 Week High
$258.23
$406.19

Technical Indicators

Market Signals
Indicator
DHR
SYK
Relative Strength Index (RSI) 57.48 56.30
Support Level $235.07 $350.02
Resistance Level $241.26 $370.88
Average True Range (ATR) 4.90 7.15
MACD 0.16 1.00
Stochastic Oscillator 65.07 77.94

Price Performance

Historical Comparison
DHR
SYK

About DHR Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Share on Social Networks: